Related Experiment Videos

Transglutaminase activity and embryonal carcinoma cell differentiation

L Uhl, J Schindler

    Experimental Cell Biology
    |January 1, 1987
    PubMed

    Insights

    Retinoic acid (RA) triggers differentiation in mouse embryonal carcinoma (EC) cells by modulating transglutaminase (TGase) activity. Inhibiting TGase blocks this RA-induced differentiation, suggesting TGase is crucial for the process.

    Area of Science:

    • Cell biology
    • Biochemistry
    • Developmental biology

    Background:

    • Embryonal carcinoma (EC) cells are pluripotent stem cells.
    • Retinoic acid (RA) is a key inducer of differentiation in EC cells.
    • Transglutaminase (TGase) is an enzyme involved in various cellular processes.

    Purpose of the Study:

    • To investigate the role of transglutaminase (TGase) in retinoic acid (RA) induced differentiation of murine embryonal carcinoma (EC) cells.

    Main Methods:

    • Murine EC cells were treated with retinoic acid (RA).
    • Transglutaminase (TGase) activity was measured following RA exposure.
    • The effect of TGase inhibitors on RA-induced differentiation was assessed in vitro.

    Main Results:

    • Retinoic acid (RA) treatment rapidly modulated transglutaminase (TGase) activity in EC cells.
    • Inhibition of TGase activity in vitro blocked RA-induced EC cell differentiation.
    • These findings indicate a direct correlation between TGase activity and EC cell differentiation.

    Conclusions:

    • Transglutaminase (TGase) activity is modulated early in the retinoic acid (RA) induced differentiation of murine embryonal carcinoma (EC) cells.
    • TGase plays a significant role in mediating RA-induced EC cell differentiation.
    • Targeting TGase may offer a novel strategy for controlling EC cell differentiation.

    Related Concept Videos